Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Re: Vangipuram et al.: Timing of delayed retinal pathology in patients presenting with acute posterior vitreous detachment in the IRIS registry (Intelligent Research in Sight). (Ophthalmol Ret. 2023:7:713-720).
Gallo B, Jalil A, Hillier RJ, Costen M, Sandinha MT, Steel DH, Winder S, Ch'ng SW, Saidkasimova S, Charles S, Chandra A. Gallo B, et al. Among authors: jalil a. Ophthalmol Retina. 2024 May 6:S2468-6530(24)00173-8. doi: 10.1016/j.oret.2024.03.023. Online ahead of print. Ophthalmol Retina. 2024. PMID: 38727670 No abstract available.
CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.
Xiang Y, Mata-Garrido J, Fu Y, Desterke C, Batsché E, Hamaï A, Sedlik C, Sereme Y, Skurnik D, Jalil A, Onifarasoaniaina R, Frapy E, Beche JC, Alao R, Piaggio E, Arbibe L, Chang Y. Xiang Y, et al. Among authors: jalil a. EMBO Mol Med. 2024 Apr 29. doi: 10.1038/s44321-024-00066-6. Online ahead of print. EMBO Mol Med. 2024. PMID: 38684864 Free article.
Cross-continental national nutrition surveys: a narrative review.
Alkhaldy AA, Aljaadi AM, Jalil AMM, Alyoubi DA, Saleemani HH, Eid RH, Almohmadi NH, Al-Otaibi HH, Ajabnoor SM. Alkhaldy AA, et al. Among authors: jalil amm. BMC Nutr. 2024 Apr 22;10(1):63. doi: 10.1186/s40795-024-00868-4. BMC Nutr. 2024. PMID: 38649978 Free PMC article. Review.
Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial.
Paton NI, Gurumurthy M, Lu Q, Leek F, Kwan P, Koh HWL, Molton J, Mortera L, Naval S, Abu Bakar Z, Pang YK, Lum L, Lim TK, Cross GB, Lekurwale G, Choi H, Au V, Connolly J, Hibberd M, Green JA; Pascolizumab Tuberculosis Trial Team. Paton NI, et al. J Infect Dis. 2024 Mar 25:jiae104. doi: 10.1093/infdis/jiae104. Online ahead of print. J Infect Dis. 2024. PMID: 38527849
535 results